Xtant Medical Holdings, Inc.
XTNT
$0.612
-$0.008-1.29%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.26% | 18.05% | 12.11% | 11.66% | 48.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.26% | 18.05% | 12.11% | 11.66% | 48.00% |
| Cost of Revenue | -2.06% | 19.77% | 41.18% | 20.08% | 46.16% |
| Gross Profit | 30.69% | 17.00% | -6.49% | 6.35% | 49.15% |
| SG&A Expenses | -8.61% | -7.45% | -15.00% | 6.33% | 52.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.39% | 1.59% | 4.64% | 11.65% | 52.10% |
| Operating Income | 256.96% | 130.63% | 50.55% | -11.58% | -111.79% |
| Income Before Tax | 199.48% | 100.76% | 15.62% | -171.59% | -75.70% |
| Income Tax Expenses | 608.33% | -136.76% | -96.36% | 102.70% | 176.92% |
| Earnings from Continuing Operations | 191.95% | 101.32% | 26.45% | -154.43% | -76.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 191.95% | 101.32% | 26.45% | -154.43% | -76.30% |
| EBIT | 256.96% | 130.63% | 50.55% | -11.58% | -111.79% |
| EBITDA | 397.38% | 186.69% | 73.68% | -8.07% | -231.29% |
| EPS Basic | 186.15% | 101.18% | 39.58% | -151.67% | -47.26% |
| Normalized Basic EPS | 192.93% | 100.48% | 41.23% | -15.00% | -47.20% |
| EPS Diluted | 166.67% | 101.18% | 39.58% | -157.14% | -49.25% |
| Normalized Diluted EPS | 186.96% | 100.48% | 41.23% | -21.69% | -47.20% |
| Average Basic Shares Outstanding | 6.94% | 6.81% | 21.71% | 5.43% | 19.63% |
| Average Diluted Shares Outstanding | 14.05% | 10.09% | 21.71% | -0.42% | 19.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |